Sex-specific cardiovascular drug dosages needed to reduce adverse reactions in women

(European Society of Cardiology) Sex-specific cardiovascular drug dosages are needed to reduce adverse reactions in women, according to a position paper from the European Society of Cardiology published today in the June issue of European Heart Journal - Cardiovascular Pharmacotherapy.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2suSVhE